+
Site Tour

EuroPCR 2023: Improving outcomes in mitral regurgitation

Francesco Maisano, Marianna Adamo, Alison Duncan, Georg Nickenig and Greg Stone discuss the role of COAPT trial evidence in reducing mitral regurgitation and securing optimal outcomes for patients. Points also discussed include patient selection, repair or replacement, and real-world registry evidence on reducing MR with TEER.

Related Videos

EuroPCR 2023: Defining the future

EuroPCR 2023: Vascular access

EuroPCR 2023: Tricuspid valve

EuroPCR 2023: COAPT 5-year follow-up

Now you've got Navitor. Remarkable performance.

TAVI 2023: Optimizing TAVI

Navitor™: Voice of the Experts Lars Sondergaard

Now you've got Navitor

A decade of Tendyne: C. Klein and P. Denti

TAVI Summit - Cardiac imaging and morphology

Navitor™: Voice of the Experts Federico de Marco

TAVI Summit - TAVR in bicuspid

TRENDING TOPICS

Advanced TAVI webinars - Module 2

Navitor Cusp overlap implantation technique for optimized outcomes 

EuroPCR 2025 Symposium: TAVI

Optimising self-expandable TAVI clinical outcomes without compromise

The Shift In My Practice: PFO Closue

The Shift In My Practice: PFO Closure
Barry Love, MD and Lili Velickovic Ostojic, MD

CONNEXT


HUB
RELATED RESOURCES

bRIGHT study

Data Summary PFO closure in patients > 60 Years

bRIGHT 2-year real-world outcomes

Epic Mitral – 10-Year Clinical Outcomes

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit 2023: Aortic stenosis

AV VALVES 2023: Staged, Concomitant

Navigating the Anatomy | Mitral focus

TAVI Summit - Cardiac imaging

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline